Previous Article | Next Article ![]()
Journal of Virology, February 2000, p. 1641-1647, Vol. 74, No. 4
Centro de Biología Molecular
"Severo Ochoa" (CSIC-UAM), Universidad Autónoma de Madrid,
Cantoblanco, 28049 Madrid,1 and
Department de Química Orgánica, Universitat de
Barcelona, 08028 Barcelona,2 Spain, and
Institut für Biochemie, University of Giessen, D-35392
Giessen, Germany3
Received 16 July 1999/Accepted 10 November 1999
Cell surface molecules that can act as virus receptors may exert an
important selective pressure on RNA viral quasispecies. Large
population passages of foot-and-mouth disease virus (FMDV) in cell
culture select for mutant viruses that render dispensable a highly
conserved Arg-Gly-Asp (RGD) motif responsible for integrin receptor
recognition. Here, we provide evidence that viability of recombinant
FMDVs including a Asp-143
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cell Recognition by Foot-and-Mouth Disease Virus
That Lacks the RGD Integrin-Binding Motif: Flexibility in Aphthovirus
Receptor Usage

Gly change at the RGD motif was conditioned
by a number of capsid substitutions selected upon FMDV evolution in
cell culture. Multiply passaged FMDVs acquired the ability to infect
human K-562 cells, which do not express integrin
v
3. In contrast to previously described
cell culture-adapted FMDVs, the RGD-independent infection did not
require binding to the surface glycosaminoglycan heparan sulfate (HS).
Viruses which do not bind HS and lack the RGD integrin-binding motif
replicate efficiently in BHK-21 cells. Interestingly, FMDV mutants
selected from the quasispecies for the inability to bind heparin
regained sensitivity to inhibition by a synthetic peptide that
represents the G-H loop of VP1. Thus, a single amino acid replacement
leading to loss of HS recognition can shift preferential receptor usage of FMDV from HS to integrin. These results indicate at least three different mechanisms for cell recognition by FMDV and suggest a
potential for this virus to use multiple, alternative receptors for
entry even into the same cell type.
*
Corresponding author. Mailing address: Centro de
Biología Molecular "Severo Ochoa" (CSIC-UAM), Universidad
Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain. Phone:
34-91-3978485. Fax: 34-91-3974799; E-mail:
edomingo{at}cbm.uam.es.
Present address: Department of Neuropharmacology, The Scripps
Research Institute, La Jolla, CA 92037.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|